Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMRA (Biomerica) -- Ignore unavailable to you. Want to Upgrade?

To: Leman who wrote (102)	7/28/1998 10:17:00 AM
From: Leman	Read Replies (1) \| Respond to of 170

Market Analysis EZ Detect EZ Detect is manufactured by the public company Biomerica which has a primary focus on medical diagnostic testing. Biomerica, which was founded in 1971, is rated by the 1994 Thomas Register of American Manufacturers to be worth $25,000,000. The 1992 Ward's Business Directory reported that Biomerica had sales of $8.5 million and 100 employees. Its officers include: Joseph H. Irani, President and CFO; Zack Irani, Director of Marketing; Mark Fisher, Data Processing Manager. Zack Irani was quoted in a recent article in Pharmacy Times as saying, "Doctors like our home testing products because the process leads to earlier disease detection and greater compliance once the patient becomes aware of a health problem." Some subsidiaries of Biomerica include Lancer Orthodontics Inc., Allergy Immunotechnologies Inc., and Synorex. Its NASDAQ symbol is BMRA.